Gastroenterology Doctors in Mentor, OH Accepting Medicare

7 Gastroenterology doctors found. Showing 1 - 7

Dr. Keith Alan Friedenberg, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 8877 Mentor Ave, Mentor, OH 44060 Phone: 440-205-1225    Fax: 440-205-1275

Ahmad Ascha, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 9500 Mentor Ave, Suite 340, Mentor, OH 44060 Phone: 440-352-9400    Fax: 440-352-9407

Emily E Carey, DO Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 9500 Mentor Ave, Mentor, OH 44060 Phone: 440-352-9400

Dr. Sayed S Khatami, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 8877 Mentor Ave, Mentor, OH 44060 Phone: 440-205-1225    Fax: 440-205-1275

Bridget Marie Gallagher, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 8877 Mentor Ave, Mentor, OH 44060 Phone: 440-205-1225    Fax: 440-205-1275

Rami Abbass, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 9000 Mentor Ave # 204, Mentor, OH 44060 Phone: 440-708-1555    Fax: 440-708-1515

Keyur P Parikh, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 8877 Mentor Ave, Mentor, OH 44060 Phone: 440-205-1225    Fax: 440-205-1275

News Archive

Latest sequencing targets for NHGRI

The National Human Genome Research Institute (NHGRI) has announced several new sequencing targets including the Northern white-cheeked gibbon (Nomascus leucogenys).

States combat health costs, workforce and safety issues

"The Massachusetts Senate is weighing a bill aimed at curbing soaring health care costs for individuals and small businesses. Senate President Therese Murray says the bill will ease market instability, smooth out annual fluctuations in premiums and require insurers [to] offer affordable small business plans" (5/18).

Cell Therapeutics to sell $16.0 million of shares of Series 12 Preferred Stock and warrants

Cell Therapeutics, Inc. today announced that it has entered into an agreement to sell, subject to customary closing conditions, approximately $16.0 million of shares of its Series 12 Preferred Stock and warrants to purchase shares of its common stock in a registered offering to three institutional investors.

Insurance execs defend rate hikes before Congress

Lawmakers said Anthem Blue Cross, the California insurer that proposed raising premium rates for some individual policyholders by as much as 39 percent, sought to boost profits at the expense of its insured, the Los Angeles Times reports. During a congressional hearing Wednesday, "Democrats said internal documents from [Anthem's parent firm] WellPoint Inc. showed that proposed rate increases of as much as 39% for California customers who buy individual policies would 'return California to a profit of 7%.'"

Read more Medical News

› Verified 6 days ago